Cognitive Deficits Terminated Phase Trials for Benzalkonium (DB11105)

Also known as: Cognitive Decline / Cognitive Deficit / Cognitive Dysfunction / Impaired cognition (finding) / Cognitive impairment / Cognitive disturbance / Cognitive function abnormal

IndicationStatusPhase
DBCOND0044823 (Cognitive Deficits)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02232477Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in MPS ITreatment